|
Market Closed -
NYSE
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 9.400 USD | -43.17% |
|
-44.71% | -69.68% |
Company Valuation: Pelthos Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 3.864 | 95.69 | 35.99 | - | - |
| Change | - | 2,376.4% | -62.39% | - | - |
| Enterprise Value (EV) | 3.864 | 95.69 | 35.99 | 35.99 | 35.99 |
| Change | - | 2,376.4% | -62.39% | 0% | 0% |
| P/E | -0.45x | -1.35x | -0.52x | -2.42x | 4.58x |
| PBR | - | - | - | - | - |
| PEG | 0x | -0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 5.7x | 0.58x | 0.33x | 0.23x |
| EV / Revenue | - | 0x | 0.58x | 0.33x | 0.23x |
| EV / EBITDA | - | -0x | -1.07x | 16.4x | 1.52x |
| EV / EBIT | - | -0x | -0.74x | -3.16x | 1.86x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -14.3 | -23.04 | -18 | -3.88 | 2.052 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | 16.8 | 62.36 | 108.4 | 155.7 |
| EBITDA 1 | - | -24.68 | -33.75 | 2.2 | 23.6 |
| EBIT 1 | - | -32.43 | -48.8 | -11.39 | 19.31 |
| Net income 1 | -7.955 | -43.32 | -65.56 | -28.76 | 7.022 |
| Net Debt | - | - | - | - | - |
| Reference price 2 | 6.410 | 31.000 | 9.400 | 9.400 | 9.400 |
| Nbr of stocks (in thousands) | 603 | 3,087 | 3,828 | - | - |
| Announcement Date | 3/27/25 | 3/19/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52x | - | - | - | 35.99M | |
| 41.42x | 14.04x | 31.11x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.33% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 106.24x | 6.06x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.59x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -41.18x | 7.46x | 46.76x | 1.93% | 212B | |
| Average | 28.16x | 7.39x | 21.65x | 2.01% | 426.2B | |
| Weighted average by Cap. | 37.16x | 8.83x | 22.81x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PTHS Stock
- Valuation Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
